IL131279A0 - Mediation of cytokines by melanin - Google Patents

Mediation of cytokines by melanin

Info

Publication number
IL131279A0
IL131279A0 IL13127998A IL13127998A IL131279A0 IL 131279 A0 IL131279 A0 IL 131279A0 IL 13127998 A IL13127998 A IL 13127998A IL 13127998 A IL13127998 A IL 13127998A IL 131279 A0 IL131279 A0 IL 131279A0
Authority
IL
Israel
Prior art keywords
melanin
mediation
cytokines
Prior art date
Application number
IL13127998A
Other languages
English (en)
Original Assignee
Stanford Res Inst Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stanford Res Inst Int filed Critical Stanford Res Inst Int
Publication of IL131279A0 publication Critical patent/IL131279A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
IL13127998A 1997-02-12 1998-02-10 Mediation of cytokines by melanin IL131279A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/798,846 US6242415B1 (en) 1997-02-12 1997-02-12 Mediation of cytokines by melanin
PCT/US1998/002971 WO1998034602A2 (en) 1997-02-12 1998-02-10 Mediation of cytokines by melanin

Publications (1)

Publication Number Publication Date
IL131279A0 true IL131279A0 (en) 2001-01-28

Family

ID=25174420

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13127998A IL131279A0 (en) 1997-02-12 1998-02-10 Mediation of cytokines by melanin

Country Status (9)

Country Link
US (1) US6242415B1 (xx)
EP (1) EP0967973A2 (xx)
JP (1) JP2001512446A (xx)
KR (1) KR20000071029A (xx)
AU (1) AU744734B2 (xx)
CA (1) CA2279946A1 (xx)
IL (1) IL131279A0 (xx)
WO (1) WO1998034602A2 (xx)
ZA (1) ZA981071B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI991896A1 (it) * 1999-09-09 2001-03-09 Carlo Ghisalberti Melanine e pigmenti vegetali
EP1613206A2 (en) * 2003-04-16 2006-01-11 The University Of Mississippi Immunostimulatory agents in botanicals
JP6889458B2 (ja) * 2016-08-05 2021-06-18 学校法人中部大学 細胞増殖抑制剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987202A (en) 1974-05-30 1976-10-19 Okun Milton R Method of treating psoriasis
US5210076A (en) * 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
US5057325A (en) * 1990-03-20 1991-10-15 Vanderbilt University Method of inhibiting replication of HIV with water-soluble melanins
US5340734A (en) 1992-11-25 1994-08-23 Biosource Genetics Corporation Method for making stable, extracellular tyrosinase and synthesis of polyphenolic polymers therefrom

Also Published As

Publication number Publication date
WO1998034602A3 (en) 1998-11-05
US6242415B1 (en) 2001-06-05
ZA981071B (en) 1999-05-04
WO1998034602A2 (en) 1998-08-13
JP2001512446A (ja) 2001-08-21
CA2279946A1 (en) 1998-08-13
AU744734B2 (en) 2002-02-28
KR20000071029A (ko) 2000-11-25
EP0967973A2 (en) 2000-01-05
AU6168598A (en) 1998-08-26

Similar Documents

Publication Publication Date Title
GB2313744B (en) Telecommunications
GB2326558B (en) Headset
PL337442A1 (en) Expression adjustment of quinolane phosphoribozyltransferase
GB2327382B (en) Shower Head
HUP0004018A2 (en) Telephone set
AU1205599A (en) Suppressor of cytokine signaling
AU7687698A (en) Face mask
ZA981071B (en) Mediation of cytokines by melanin
AU133459S (en) Telephone set
GB2323652B (en) Means of assembly
EP0778398A4 (en) CERAMIC SLIDING COMPONENTS
AU5942598A (en) Railtrack bearer
GB9704071D0 (en) Cytokines
AU8539798A (en) Casting nozzle
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps
TW351499U (en) Improvement of intermediate connetor for telephone
TW357554U (en) Improvement of shinguards
IL114944A0 (en) Disposable cellular phone-set
CA79365S (en) Set of dinnerware
TW364360U (en) Improvement on structure of syringe
TW357952U (en) Improvement of microphone structure
TW314782U (en) Improved structure of mask
TW398283U (en) Improved structure of mask
GB9722379D0 (en) Continuous casting